Arrhythmia
Read Time: 2 mins

7/Outcomes from a ‘low biventricular pacing’ MDT service

Published Online: October 9th 2012 European Journal of Arrhythmia & Electrophysiology. 2022;8(Suppl. 1):abstr7
Authors: BJ Jones (Presenting Author) – Barts Health NHS Trust, London; JR Ramplin – Barts Health NHS Trust, London; ZC Carter – Barts Health NHS Trust, London; NM Mark – Barts Health NHS Trust, London; PL Lloyd – Barts Health NHS Trust, London; BP Patel – Barts Health NHS Trust, London; SC Cowap – Barts Health NHS Trust, London; HG Granville – Barts Health NHS Trust, London; AM Muthumala – Barts Health NHS Trust, London
Quick Links:
Article
Article Information
Article:

Introduction: A greater biventricular pacing percentage (BiVp%) is associated with greater left ventricular reverse remodelling and reduction in all-cause mortality in patients with cardiac synchronisation therapy devices (CRT). A multi-disciplinary team (MDT) service was implemented at Barts Health NHS Trust to discuss patients with low BiVp%, to determine the cause, increase BiVp%, and provide a clear management plan to aid cardiac scientists when responding to remote monitoring alerts.

Methods: This retrospective audit followed 121 patients who were referred to the low BiVp% service between June 2020 and July 2021. 106 patients were included in the analysis, of the excluded patients, 11 were deceased at 6 months, 3 had been transferred to another centre and one patient had left ventricular (LV) lead displacement. Baseline characteristics were collected at time of CRT implant and BiVp% and New York Heart Association (NYHA) functional class were collected at the time of MDT and 6-month post MDT. The outcome of the MDT was actioned and documented on patients’ electronic health records.

Results: Of the 106 patients, 75% were male, mean age was 73 ± 10.6 years, mean LV ejection fraction (LVEF) at implant was 33 ± 11% and 57% were classed as NYHA II. The most common indication for implant was ischaemic heart disease (49%), and the most common QRS morphology was left bundle branch block (58%). The most common outcomes were to continue patient monitoring (35%) and lowering the alert threshold on remote monitoring (27%). In the remaining 40 patients, an active outcome was actioned, most commonly a referral to another cardiology service (19%). The other outcomes are summarised in Table 1. These 40 patients had a mean improvement in BiVp% of 6 ± 12% over a mean follow-up time of 5.9 ± 1.6 months post-MDT. An improvement of ≥1 NYHA class was seen in 16 patients (44%), no change in NYHA class was seen for 12 (33%) symptomatic patients (NYHA II-IV), no change in NYHA class was seen in 6 (16%) asymptomatic patients (NYHA I) and 2 patients showed a worsening of ≤1 NYHA class at a mean follow-up time of 5.9 ± 1.6 months post-MDT.

Conclusion: This retrospective audit has demonstrated that in 38% of patients being discussed in a ‘low biventricular pacing MDT’, active changes were made to their clinical care. These patients had an improvement in biventricular pacing and around half had improved NYHA class over a short follow-up period. Changing alert threshold was a useful outcome for cardiac scientists when managing remote monitoring alerts. Future prospective studies should evaluate the outcomes over a longer follow-up duration. 

Further Resources

Share this Article
Related Content In Arrhythmia
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72